---
$id: https://graph.org.ai/products/commodity/51313103
$type: Product
source: UNSPSC
code: "51313103"
title: "Clocinizine"
class: "51313100"
classTitle: "Antihistamine or H1 blocker piperazines"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clocinizine

**UNSPSC Code**: 51313103
**Class**: [Antihistamine or H1 blocker piperazines](Antihistamine or H1 blocker piperazines.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8HQJ711KH8. European Medicines Agency schedules Clocinizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06685MIG. Clocinizine generally arises in the molecular formula C26H27CLN2. The term CLOCINIZINE is an International Non-Proprietary Name or INN. CLOCINIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clocinizine under HS 29335995 and SITC 51576. As of Q4 2014, CLOCINIZINE remains the US FDA Preferred Term for this commodity. Clocinizine bears US NLM identifiers UMLS ID C1322002 and NCI Concept Code C77435. SMILES: CLC1CCC(C(N2CCN(CC2)C/C=C/C2CCCCC2)C2CCCCC2)CC1.

